Wolfgang Fischer
Operationeel Directeur bij AFFIMED N.V.
Vermogen: 633 086 $ op 31-05-2024
Profiel
Wolfgang Fischer is currently the Chief Operating Officer at Affimed NV and Affimed GmbH.
He previously worked as the Regional Medical Director-Hematology at Novartis Pharma Schweiz AG.
He holds a doctorate degree from the Swiss Federal Institute of Technology and the University of Würzburg Medical School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
AFFIMED N.V.
0.96% | 15-03-2024 | 145 537 ( 0.96% ) | 633 086 $ | 31-05-2024 |
Actieve functies van Wolfgang Fischer
| Bedrijven | Functie | Begin |
|---|---|---|
| AFFIMED N.V. | Operationeel Directeur | 13-09-2017 |
Affimed GmbH
 Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Operationeel Directeur | 01-01-2017 |
Eerdere bekende functies van Wolfgang Fischer
| Bedrijven | Functie | Einde |
|---|---|---|
Novartis Pharma Schweiz AG
 Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Corporate Officer/Principal | - |
Opleiding van Wolfgang Fischer
| Swiss Federal Institute of Technology | Doctorate Degree |
| University of Würzburg Medical School | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AFFIMED N.V. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Novartis Pharma Schweiz AG
Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland. | Commercial Services |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Commercial Services |
